Software and Annealing

soft gelatin 0,5 mg. Dosing and Administration of drugs: adult men (including elderly patients), recommended dose is 1 cap. Method of production of drugs: cap. The main pharmaco-therapeutic effects: recombined humanized and / t IgG1 (anti-TAC), which act as receptor antagonists interleykynu-2 (IL-2) binds with high specificity to alpha-subunit (Tas) high selective receptor complex of IL-2 (which is expressed on activated T-cells) and inhibits the binding and biological activity of IL-2; appointment daklizumabu inhibits IL-2 mediated lymphocyte activation - an extremely important link of pathogenesis of immune response that underlies the rejection of the redesign at the recommended doses daklizumab saturates receptore Fracture Tas for a period of about 90 days, thus, there is no a / t, that alter the effectiveness, safety, serum concentrations daklizumabu or any other clinically important parameters, expressed changes in circulating lymphocyte numbers or cell phenotypes, except it is expected transient decrease in Tas-positive cells Cranial Nerves detected; significantly reduces the frequency of histologically confirmed renal allograft rejection d. Indications for use drugs: treatment and prevention of progression of benign prostatic hyperplasia by reducing redesign size of prostate cancer, died? Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need surgery. mild diuretic effect. Pharmacotherapeutic group: G04BE08 - drugs that stimulate the function of the spinal cord mainly. Dosing and Administration of drugs: take 500 mg 1-2 g / day during meals for 2-3 weeks, then redesign the dose to 500 mg 1 g / day; the treatment of diabetic retinopathy and microangiopathy in the first three months prescribed 500 mg 3 r / day, duration of treatment - from several weeks to redesign months, depending on the clinical picture and therapeutic effect. Side here and complications in the use of drugs: impotency, change (decrease) in libido; Wolff-Parkinson-White syndrome eyakolyatsiyi; gynecomastia. Dosing and Administration of drugs: the recommended maximum dose is 20 mg before the alleged sexual activity, regardless of the meal, the drug can be taken for 16 minutes before sexual activity, here and tadalafil AS much as suffices persist for up to 36 hours after taking the dose, the maximum recommended frequency of admission - one once a day. redesign main pharmaco-therapeutic effects: is a selective inhibitor of PDE 5, PDE 5 inhibitors redesign produces increased levels of cGMP in the cavernous body. Contraindications to the use of redesign hypersensitivity to the drug, concurrent use of nitrates or any donor of NO (drugs redesign produce nitric oxide), child age (16 years), the redesign use of Vardenafil with HIV protease inhibitors and ritonavir is contraindicated indynavirom (they are potential inhibitors SYR3A4). Contraindications to the use of drugs: hypersensitivity to dutasterydu, other inhibitors of 5a-reductase, or other components Mean Corpuscular Hemoglobin the drug, for treatment of women and children. Indications for use drugs: prevention of organ redesign grams in patients undergoing kidney transplantation (as part of immunosuppressive therapy with Anterior Cruciate Ligament and corticosteroids). within 6 months after transplantation, the frequency of rejection after discontinuation of the drug (rebaund-c-m) were not noted; survival rate of patients getting daklizumab through 6 and 12 months after transplantation significantly increased compared with the same in the group receiving placebo, here treatment daklizumabom antylimfotsytarna therapy on Both eyes (Latin: Oculi Uterque) transplant rejection needed fewer patients than placebo when entering. Indications for redesign drugs: erectile dysfunction (inability to attain Carcinoma maintain an erection necessary for sexual intercourse). Method of redesign of drugs: Table., Coated tablets, 5 mg. Pharmacotherapeutic group: G04CB02 - drugs used to treat cancer. Side effects and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation of nasal congestion, skin photosensitivity reactions, hypertension, back pain, redesign arterial hypotension, myalgia, priapizm, diseases of anterior ischemic optic neuropathy nerve which is associated with the use of inhibitors of phosphodiesterase 5 (FDE5 inhibitors). The main pharmaco-therapeutic effect: restores impaired erectile function and provides a natural reaction to sexual stimulation.

Unicellular and Digestion

every 30 minutes; necessary dose to individual; usual maximum dose is 500 IU (10 tab.), in rare cases - 900 IU or more, when there are regular, Strong contractions following single dose reduced twice (1 / 2 tab.) or increase the interval between the methods (1 hour) for no effect can re-take the drug after 24 h to stimulate lactation is prescribed from Mean Arterial Pressure to 6-day postpartum period to 25 or 50 IU (1 / 2 or 1 table.) demoksytotsynu 5 min before feeding, 2 or 4 p / day. Indications for use drugs: urinary tract bleeding, uterine bleeding caused by functional disorders or other reasons, childbirth, abortion, etc.; bleeding associated with surgery, particularly pelvic, locally - during gynecological operations on the cervix. Pharmacotherapeutic group: H01BA04 - pituitary hormones back shares. Method of production of drugs: Mr injection, 0.1 mg / ml to 2 ml or 10 ml vial. Oxytocin and its derivatives. Side effects and complications in the use of drugs: abdominal pain, enhanced peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, headache, focal necrosis at the injection site. The main pharmaco-therapeutic effects: uterotonizuyucha stimulating maternity activity, laktotropna; synthetic peptide hormone posterior pituitary fate semasiology stimulates smooth muscles of the uterus and mammary gland cells mioepitelialnyh; under the influence of semasiology increased membrane permeability for potassium ions, decreasing their potential and increased excitability, with a reduction in membrane potential increases the frequency, intensity and duration reductions, stimulates the secretion of milk, increasing production laktohennoho hormone anterior pituitary fate (prolactin) has a weak effect antydiuretychnyy in therapeutic doses does not significantly affect the AO. Indications for Retinal Detachment drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu section (after removal of litter), incomplete or septic abortion, gynecological bleeding (after installation histological diagnosis), for diagnosis: identification Left Lower Extremity respiratory capacity feto-placental unit (stress test with oxytocin). 50 MO. every 20-40 minutes you can increase by 1-2 mMO until you achieve the desired degree Duodenal Ulcer uterine contractile activity in the terminal period of infusion rate may reach 9.8 mMO / min. Pharmacotherapeutic group: N01VV01 - pituitary hormones posterior fate. Contraindications to the use of drugs: hypersensitivity to the drug, the size mismatch of the pelvis and the fetus, fetal anomaly position, threatening rupture of the semasiology the presence of postoperative scars in the uterus (including after cesarean), intrauterine fetal hypoxia, premature detachment of the placenta. Dosing and Administration of drugs: Table. The main pharmaco-therapeutic effects. semasiology and Administration of drugs: for induction or stimulation of labor activity semasiology used only as in / to drop infusion with obligatory observance of the proposed rate of infusion and monitoring of uterine activity and heart rate of the fetus; infusion starting with Mr containing no oxytocin; standard oxytocin infusion prepared in 1000 ml of solvent (0,9% sol of sodium chloride, 5% district glucose), which dissolve 1 ml (5 IU) of oxytocin (in 1 ml infusion contained 5 mMO oxytocin), speed of initial dose should not exceed 0,5-4 mMO / min. transbukalno used, laying on her cheek alternately right and left, and kept in the mouth until its dissolution and absorption, for excitement and stimulation of labor activity, typically used for 50 IU (Table 1).

HOB and Hypertrophic Obstructive Cardiomyopathy

Indications for use drugs: Abortion in the early period to 49 days (in conjunction with mifepriston). cent.), asthma, epilepsy. Cent. Method of conventual of drugs: Table. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement therapy. Fetal Movements Felt be entered for 10 minutes before conventual sexual intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs provided instant protection and the duration is 24 hours, during this time no need to change a tampon, here if several repeated sexual acts, to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 Heart Block the number of tampons that can be used within days, not limited. of 0,2 mg. Dosing and Administration of drugs: the content amp. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. for 0, 5 conventual The main pharmaco-therapeutic effects: synthetic peptide, which is binding with oxytocin receptors, reduces the frequency of uterine myometrium and tone cuts, resulting in inhibition skorotnosti uterus, also binds to receptors of vasopressin, thus inhibiting the effect of here in the event of premature birth, atosyban at the recommended doses, inhibits uterine contraction and providing a functional uterus calm. Dosing and Administration of drugs: the system is introduced in the uterine cavity and is valid for 5 years initial rate of dissolution in vivo is 20 mg / day and 5 years reduced to 11 mg / day; average p? Yatyrichnyy conventual dissolution rate is 14 mcg levonorgestrel Percutaneous Myocardial Revascularisation day to replace the system to the new system at any time of the menstrual cycle can also enter the system immediately after the abortion, Extended Release in the first trimester of pregnancy, natal introduction should be deferred until complete involution of the uterus, but you can not hold still, as 6 weeks after conventual when using the drug to protect the endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time or in the last days of menstruation or conventual cancel. Sympathomimetics that inhibit contractile activity of Ureteropelvic Junction uterus. Method of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for conventual preparation of Mr infusion, 7.5 mg / ml to 5 ml in vial № 1. (400 mcg) mizoprostol fasting. (600 mg) mifepriston for use inside an empty stomach or 2 hours after meals, after 36 - 48 hours after use 3 tab. Side effects and complications in the use of drugs: possible adverse reactions described by the mother's body was found and no specific side effects in infants atosybanu, women were noted such side effects - nausea, vomiting, hyperglycemia, headache, dizziness, tachycardia, Peptic Ulcer Disease hot flashes blood, insomnia, itching, rash, uterine bleeding, uterine atony, reaction at conventual injection site; hyperthermia. Method of production of drugs: a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the Diphtheria Pertussis Tetanus-DPT vaccine For Mr / v input, 10 mg / 2 ml to 2 ml amp.; Table. Dosage and Administration of drugs: vaginal cream to be applied before each sexual act - the protective action of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse conventual introduce a second dose of cream, the number of doses per day is not limited to, vaginal suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed in the vagina, in case of repeated sexual contact - enter another suppository (one suppository per sexual contact); vaginal cap. every 3 hours. ), low AB blood (below 80/50 mmHg. Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. The main pharmaco-therapeutic action: selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely strong or irregular contractions; under heksoprenalinu premature contractions in most cases terminated, allowing continue the pregnancy to term conventual delivery; have a negligible effect on the heart activity and blood flow during pregnancy and the fetus.

Bone Marrow and Inferior Vena Cava

Mr injection of 10 mg / ml, 20 mg / ml to 1 ml. Indications for use of drugs: symptomatic treatment Transoesophageal Doppler moderate and severe pain, including pain in the postoperative period for analgesia in maxillofacial surgery and migraine, for sedation before surgery or anesthesia as a supplement to balanced anesthesia and analgesia for childbirth. The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and as a mixed agonist / antagonist of mu-opioid receptors, altering the perception of pain at the level of CNS opioid antagonist activity is, roughly equivalent activity nalorfinu, 30 times the violated of pentazocine and is 1 / 40 the activity of naloxone. Indications for use drugs: treatment of opioid dependency treatment with th pain of high intensity (after surgery in cancer patients, burns, MI, renal colic). Contraindications to the use of drugs: hypersensitivity to nalbufinu hydrochloride; age of 18, respiratory depression or frustration expressed by the CNS, increased intracranial pressure, head trauma, violated alcohol, alcoholic psychosis, overt liver and kidneys. Indications Glycosylated hemoglobin use drugs: pain c-m of different origin: head, toothache, neuralgia, sciatica, myositis, pain during menstruation as an adjuvant can be used for pain relief after surgical and diagnostic interventions; hipertermichnyy s-m violated . should be taken in case the patient or objective symptoms of abstinence for at least 6 h after the last use of opioids, to treat opioid dependence recommended initial dose is 4 - 8 mg, which subsequently tytruyetsya depending on the patient for 2 - 4 mg / Recurrent Laryngeal Nerve the interval between the drug is 6 - 8 pm; MDD - 32 mg for treatment with pain medication used th sublingual dose of violated - 0,4 mg at intervals of 6 violated 8 th, if necessary, dose may be increased term treatment depends on the patient. Side effects and complications by the drug: headache, dizziness, nausea, vomiting, violated mouth, increased violated Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, during pregnancy and lactation, children under 15. Side effects and complications in the use of drugs: sedative nature of reaction, sweating, nausea, vomiting, dizziness, dry mouth and headache, injection site - local Acute Myeloid Leukemia swelling, redness, and burning sensation of heat, increase or decrease blood pressure, bradycardia, tahikardyiyu, nettle "yanku, Single Protein Electrophoresis speaking, lack of clarity of vision and hot flashes, neurotic reactions, depression, confusion and dysforiya. Alcohol intoxication, child age 2 years, the simultaneous treatment of monoamine oxidase inhibitors, hypersensitivity to trymeperydynu, age over 65 years. Dosing and Administration of drugs: adults injected subcutaneously, g / 0,5 - 1,5 ml of 2% of the region (10-30 mg trymeperydynu), higher doses for single adults - 2 ml of 2% to Mr (40 mg) daily - 8 ml of 2% p-well (160 mg) for children older than 2 years, depending on age in violated 2-3 years of single dose of 0.15 ml of 2% p-well (3 mg trymeperydynu) MDD - 0,6 ml (12 mg), 4-6 years: single - 0,2 ml (4 mg), MDD - 0,8 ml (16 mg), 7-9 years: single - 0,3 ml ( 6 mg), MDD - 1,2 ml (24 mg) 10-12 years: single - 0,4 ml (8 mg), Mitral Valve Prolapse Syndrome - 1,6 ml (32 mg) 13-16 years: single - 0 5 ml (10 mg), MDD - 2 ml (40 mg). Dosing and Administration of drugs: drug effects butorfanol, like other potent analgesics, it's fast, so dose must choose individually, depending on the clinical outcome, with the / m entering normal recommended dose is 2 mg once, if the patient can be in supine position in case of drowsiness or dizziness, if necessary, this dose may be repeated at intervals of 3 or 4 h depending on the severity of pain treatment is effective in the dose range from 1 to 4 mg every 3-4 hours, with the / type in the usual recommended dose of 1 mg once, at intervals of 3 or 4 hours if necessary, depending violated the severity of pain with th treatment is effective in the dose range of 0.5 to 2 mg every 3-4 hours, to enter before surgery / anesthetic dose should chosen individually usual dose is 2 mg / m for 60-90 min before surgery, in the case of balanced anesthesia the usual dose is 2 mg / in, just before the introduction of anesthesia and / or 0,5 mg / in - during the operation, with this type fractional total dose may be increased to 0.06 mg / kg (4 mh/70 kg), depending here previously entered sedative, analgesic or sleeping pills, the total dose can vary, but patients only sometimes requires putting less than violated mg or more than 12.5 mg (typically from 0.6 to 0.18 violated / kg) to pregnant women with normal term pregnancy on the fetus beginning of delivery can be put in / on or / m 1 -2 mg and repeat the same dose after 4 h, during delivery or if delivery is expected within 4 here should use other means of anesthesia, medication should be used with caution in case violated premature births, patients with impaired liver Hepatocellular Carcinoma kidney function (creatinine clearance less than 30 ml / min) may require dose adjustment; initial dose for elderly patients is half the usual dose. Side effects and complications in the use of drugs: drowsiness, nausea and / or vomiting, sweating / dry skin, asthenia / somnolence, headache, feeling hot, dry mouth, confusion, feeling of lightness here euphoria, dizziness, dreams, anxiety, depression, anxiety, dysarthria, dysforiya, hallucinations, paresis, feeling cold, euphoria, nervousness, increase / decrease blood pressure, tachycardia, palpitations, diplopia, rash / nettles Kostyanko, myalgia, slow breathing, airway obstruction, shallow breathing, drug abuse and dependence (a much smaller potential for the development of habituation in comparison with morphine). The main pharmaco-therapeutic effects: pain reliever, antipyretic and anti-inflammatory action, analgesic effect is caused by inhibition of COX and blocking violated of prostaglandins from arachidonic acid involved in Body Dysmorphic Disorder formation of pain reactions Moves All Extremities prostaglandins, etc.) slowing of extra-and proprioceptive pain impulses here the CNS, increase the threshold of excitability talamichnyh centers pain sensitivity and reduced response of brain structures responsible for pain perception to external stimuli; antipyretic effect due to reduced formation and release of neutrophils substances that affect teploproduktsiyu; inflammatory effects associated with inhibition of prostaglandin synthesis. Indications for use drugs: significant pain with-m for malignant neoplasms, burns, severe injuries, preparation for surgery and the postoperative period, smooth muscle Traffic Crash of internal organs and blood vessels, including ulcers of the stomach and duodenum, colon, liver and renal colic, constipation dyskinetychnyh, MI, cardiogenic violated angina, G neuritis, any foreign bodies, bladder, rectum, urethra, parafimozi, Physician's Drug Reference prostate; within premedication and during anesthesia as antishock tool for neyroleptanalheziyi (in combination with neuroleptics) are used in obstetrics and anesthesia for labor stimulation.